Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2026)

Fennec Pharmaceuticals (FENC) has 5 years of Asset Utilization Ratio data on file, last reported at 0.75 in Q4 2025.

• Quarterly Asset Utilization Ratio fell 18.59% year-over-year to 0.75 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.75 (down 18.59% YoY) and the FY2025 annual result came in at 0.77, down 41.61% from the prior year.
• Asset Utilization Ratio slipped to 0.75 in Q4 2025, from 0.82 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.94 in Q1 2024 to a low of 0.01 in Q1 2021.
• A 4-year average of 0.63 and a median of 0.74 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio jumped 1115.68% — and 2025, when it decreased 27.69%.
• Tracing FENC's Asset Utilization Ratio over 4 years: stood at 0.01 in 2021, then surged by 13338.91% to 0.91 in 2023, then rose by 0.88% to 0.92 in 2024, then dropped by 18.59% to 0.75 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.75 (Q4 2025), 0.82 (Q3 2025), and 0.73 (Q2 2025), per Business Quant data.